Ensysce Biosciences
ENSC
Ensysce Biosciences (ENSC) news
Recent news
Ensysce Biosciences: awarded $5.3 mln installment in NIDA funding completing multi-year $15 mln federal grant
AInvest Wire · Jul 14, 2026ImportantEnsysce Biosciences, Inc shares fell 14.5% in pre-market trading as the company announced a 1-for-15 reverse stock split
Ensysce Biosciences, Inc shares fell 14.5% in pre-market trading as the company announced a 1-for-15 reverse stock split Ensysce Biosciences, Inc. (ENSC) experienced a significant decline in pre-market trading on December 14, 2022, following the announcement of a 1-for-15 reverse stock split [1].…
AInvest Wire · Dec 4, 2024Ensysce Biosciences jumps 27% premarket after announcing FDA Breakthrough Therapy designation granted for PF614-MPAR
AInvest Wire · Jan 23, 2024Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.